Elevated Vascular Level of ortho -Tyrosine Contributes to the Impairment of Insulin-Induced Arterial Relaxation
others -can modify phenylalanine residues to form para -, meta -and ortho -tyrosines ( p -, m -and o -Tyr) [ 11 -14 ] . Modifi ed amino acids could originate from protein-bound amino acids [ 11 ] or may be incorporated into proteins during their synthesis resulting in a polypeptide without direct oxidative damage of the protein itself [ 15 -17 ] . In line with these fi ndings, free m -Tyr was shown to be incorporated into cellular proteins, possibly via protein synthesis, which then can exert cytotoxic actions [ 17 ] . Furthermore, o -Tyr and m -Tyr levels were found to be signifi cantly higher in the aortic tissue of hyperglycemic cynomolgus monkeys and that of rats with aortic banding-induced hypertension [ 11 , 18 ] . Misincorporation of o -Tyr and m -Tyr into structural or catalytic proteins could also contribute to impaired cellular function, such as erythropoietin-hyporesponsiveness in erythroblasts and inhibition of tumor growth in vivo, possibly by interfering with MAP/ERK signaling [ 19 , 20 ] . Of note, cytotoxicity of m -Tyr can be blocked in vitro with phenylalanine [ 15 ] , suggesting that L -phenylalanine tRNA synthase recognizes m -Tyr to aff ect incorporation of ROS-damaged amino acids into cellular proteins [ 15 ] . However, Introduction ▼ Insulin is one of the major hormonal regulators of tissue metabolism, but it plays also an important role in regulating vasomotor activity [ 1 , 2 ] . Vascular eff ects of insulin could be manifested in dilation and/or constriction depending on tissues of origin [ 3 ] . The vasodilator action of insulin is primarily attributed to the release of nitric oxide (NO) produced by NO synthase in the endothelium (eNOS), which is activated via the phosphatidylinositol 3-kinase/Akt (PI3K/Akt) pathway [ 4 -6 ] . In diabetes, increased levels of reactive oxygen species (ROS) play an important role in the development of impaired vasomotor response to insulin [ 7 -9 ] . One target of the oxidative damage is proteins, which could lead to cellular dysfunction. In addition to direct damage by reactive oxidative metabolites, however, alternative pathomechanisms have been proposed, but they have received little attention. For example, superoxide can be metabolized to H 2 O 2 , which can give rise to the production of more reactive intermediates, such as hydroxyl radical (• OH) [ 10 ] , which -among 
Material and Methods

▼
Animals and experimental design
Animal experiments were carried out with the permission of the Animal Experiment Committee of the University of Pécs, Hungary. Male Sprague-Dawley rats (4-5 week-old; 90-120 g) were used in the tyrosine isomer incorporation studies. Rats were orally supplied with either 1.76 mg/day of o -Tyr or vehicle during 6 days per week for 4 weeks. In general, there were no observable diff erences between the groups. At the end of 4-week treatment, HPLC measurements and vasomotor studies were performed.
Assessment of ortho -tyrosine and tyrosine isomer incorporation into arterial segments
Proximal sections of the isolated femoral artery were hydrolyzed and then levels of phenylalanine and tyrosine isoforms were analyzed by HPLC using a fl uorescent detector [ 13 ] .
Assessment of vasomotor function
The modifi ed method described by Fésüs et al. [ 21 ] was used. Femoral rings were pre-constricted with 100 nM epinephrine. The magnitude of relaxation caused by insulin was expressed as the percentage of the isometric (Danish Multimyograph Model 610 M) contraction evoked by epinephrine, which was taken as 100 %.
Endothelial cell treatments
Primary cultures of mouse endothelial cells (ECs) were randomly assigned into 2 groups and were incubated in media containing 1) 400 μM p -Tyr (Control) and 2) 400-400 μM p -Tyr and o -Tyr for 8 days. Then the uptake of o -Tyr was analyzed. Prior to assessing eNOS phosphorylation, ECs were incubated with insulin (400 nM for 5 min) to activate endothelial nitric oxide synthase (eNOS) phosphorylation.
Assessment of tyrosine isomer incorporation in endothelial cells
The levels of protein-bound o -Tyr of ECs were analyzed by HPLC method as described by Molnár et al. [ 13 ] .
Immunoblot analyses
Immunoblot analyses to detect eNOS phosphorylation were performed as we previously described [ 22 ] . Phospho-(Ser1177)-eNOS levels were corrected for total eNOS.
Statistical analyses
Data are expressed as means ± SEM. Statistical analyses were performed with unpaired t -test, and nonparametric tests as appropriate. Statistically signifi cant diff erences were defi ned with p ≤ 0.05. Fig. 1a ). 
Results
▼
Eff ects of chronic oral o -Tyr supplementation of rats on o -Tyr levels in the vascular wall of isolated arterial segments
Eff ects of chronic o -Tyr supplementation of rats on insulin-induced relaxation of isolated femoral arteries
Original recordings of isometric tension of femoral arteries of control (nonsupplemented) rat show that insulin elicited substantial relaxation ( • ▶ Fig. 1b ), whereas a vessel of o -Tyr-treated rats exhibited reduced relaxation ( • ▶ Fig. 1c ). Summary data show a signifi cantly diminished relaxation of the femoral artery of o -Tyr-treated rats in response to insulin compared to arteries of vehicle-treated rats ( • ▶ Fig. 1d ).
Incorporation of o -Tyr into proteins of cultured endothelial cells
To investigate the incorporation of o -Tyr into endothelial proteins, we measured the relative concentration of protein-bound o -Tyr levels in endothelial cells (ECs) cultured in control conditions and o -Tyr supplemented media for 8 days. Proteins from o -Tyr-cultured ECs showed a higher o -Tyr content compared to control ECs ( • ▶ Fig. 2a ). Fig. 2b ).
Eff ects of o -Tyr on insulin-induced eNOS phosphorylation in cultured endothelial cells
Discussion
▼
In the present study, we have shown for the fi rst time that vasoincorporation of o -Tyr reduces arterial relaxation to insulin and decreases eNOS phosphorylation in ECs. We interpret these fi nding to mean that increased levels of vascular o -Tyr inhibit eNOS phosphorylation and thus reduced synthesis of NO can result in impaired relaxation to insulin.
Previous studies have shown that o -Tyr levels are increased in aortic tissues in diabetes mellitus [ 11 , 23 ] , which raised the possibility that o -Tyr content contributes to insulin-induced vasomotor dysfunction. However, diabetes is a complex disease and it is likely that many pathomechanisms are activated simultaneously. In order to elucidate the potential role of elevated cellular level of o -Tyr in modulation of insulin-induced arterial relaxation we used a model of chronic oral administration of o -Tyr. We have found that sustained oral treatment of rats with o -Tyr markedly increased vascular content of o -Tyr and at the same time impaired the insulin-induced relaxation in isolated femoral arteries. The fi ndings that vascular o -Tyr content modulates the magnitude of vasomotor responses to insulin and that increasing o -Tyr content attenuates insulin-induced vasorelaxations suggest a novel pathophysiological mechanism, which could be important in the development of not only vasomotor dysfunction, but in general, macro-and microangiopathy known to be present in diabetes mellitus. Moreover, increased level of o -Tyr due to exogenous (e. g., nutrition) [ 24 , 25 ] or endogenous sources other than diabetes mellitus, such as hypertension [ 18 ] or infl ammation [ 26 ] (known to be associated with oxidative stress) could promote o -Tyr incorporation into vascular wall and impair vasomotor function. It is known that insulin-induced relaxation is primarily mediated by eNOS derived NO (Supplementary Fig. 1S ) [ 4 -6 ] . Thus, to elucidate possible underlying mechanisms responsible for the reduced arterial relaxation to insulin, we cultured endothelial cells and investigated the eff ects of o -Tyr treatment on eNOS phosphorylation. We found that protein-bound o -Tyr levels signifi cantly increased in o -Tyr-cultured endothelial cells, which was accompanied by attenuated eNOS phosphorylation in response to insulin. These fi ndings suggest that incorporation of o -Tyr impairs eNOS function, that is, synthesis of NO, which could explain how o -Tyr interferes with NO mediated relaxation to insulin. On the basis of the fi ndings of the present and previous studies, we also propose that deterioration of the PI3K/Akt/ eNOS/NO pathway that mediates the vasorelaxation to insulin could contribute to development of vascular insulin resistance [ 4 , 5 ] .
Clinical signifi cance
Impaired regulation of tissue blood fl ow in diabetes mellitus and its consequences are major clinical problems being one of the major health burdens world-wide [ 1 , 2 ] . Thus, understanding the molecular pathomechanisms of vascular insulin resistance can have tremendous benefi cial implications for interfering and treating diabetes related vasomotor dysfunction, such as macroand micorangiopathies. Specifi cally, our study suggests that accumulation of o -Tyr in the vascular wall may contribute to the impaired insulin-induced relaxation by interfering with the production of vasodilator NO by eNOS. Patients with type 2 diabetes and chronic kidney disease (CKD) have an increased o -Tyr burden [ 13 , 14 , 23 , 27 ] , which may contribute to the development of vascular complications. Interfering with this pathway could represent a promising future strategy for the prevention and/or treatment of vascular complications in diabetes mellitus.
Limitations and future perspectives
Although, the present study demonstrates that chronic oral supplementation of o -Tyr can increase levels of o -Tyr in arterial wall tissue with functional consequences of impaired vasomotor responses to insulin, the detailed molecular signaling pathways in the vasculature need to be elucidated by further studies.
